The Brain and Spine Institute at John Theurer Cancer Center, part of Hackensack University Medical Center, is the only comprehensive neuro-oncology center in New Jersey.
Our specialized team provides customized therapies for people with primary or metastatic brain tumors, as well as care for the various neurologic complications that can occur with cancer.
You’ll receive personalized treatment from brain and spine tumor experts who trained at the world’s best academic medical centers. We offer you advanced treatments based on the latest medical research, as well as opportunities to participate in studies of promising new therapies in one of the nation’s leading centers for brain tumor clinical trials.
Our goal is to treat your brain tumor while taking into account all physical, functional, emotional, and quality of life aspects of your disease. We don’t just care for you, but about you. In fact, according to Press-Ganey surveys, 99 percent of our patients report satisfaction with their care.
U.S. News and World Report has ranked the neurosurgery program at Hackensack University Medical Center as one of the best in the country. Our neurosurgeons complete more than 100 brain and spine tumor operations each year and receive many referrals from area hospitals and cancer specialists. If your tumor is operable, we do extensive planning before and monitoring during the procedure to perform the safest and most effective operation, removing as much tumor tissue as possible while aiming to preserve vital functions such as speech. We perform all surgical procedures using the least invasive approach possible, including endonasal (through the nose) “scarless” techniques to remove pituitary tumors, craniopharyngiomas, meningiomas, and other skull base tumors.
Our Neurological Oncology Specialists
Precision Medicine and Clinical Trials
In many cases, clinical trials offer the most hope for people with brain and spine tumors. The Brain and Spine Institute ranks among the top 10 centers in the country in clinical trials for primary brain tumors, including studies evaluating new devices, innovative immunotherapies, gene therapy, and novel anticancer drugs.
The treatment of brain tumors has been a clinical challenge, with many anticancer drugs unable to penetrate tumor tissue, and tumors eventually becoming resistant to those that do. For many patients with brain and spine tumors, therefore, the greatest hope for effective treatment lies in clinical trials of investigational therapies—including those that target the molecular abnormalities driving cancer growth.
We perform a genomic analysis of each patient’s brain tumor, yielding information we use to choose the most effective treatment and the best clinical trial. Your team will match you with the clinical trial that is best for you. We also maintain a brain tumor tissue bank—a rich resource for investigators seeking to better understand the biology of cancer development and to identify new avenues of attack to improve outcomes for people with brain tumors everywhere.
High study enrollment
Eighty percent of our patients with primary brain tumors participate in clinical trials—50 times higher than the national average.
Early-phase clinical trials
The Brain and Spine Institute has its own program of Phase I clinical trials, offering opportunities to receive novel therapies being evaluated for the first time in patients.
We are a main member institution in ALLIANCE, a collaborative of the National Cancer Institute. Your care team will let you know of your eligibility for a clinical trial.